Zhou A - Search Results

1

Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation.

Huang SC, Zhou A, Nguyen DT, Zhang HS, Benz EJ Jr. Huang SC, et al. Among authors: zhou a. J Biol Chem. 2016 Dec 2;291(49):25591-25607. doi: 10.1074/jbc.M116.761296. Epub 2016 Oct 25. J Biol Chem. 2016. PMID: 27780863 Free PMC article.

2

RBFOX2 promotes protein 4.1R exon 16 selection via U1 snRNP recruitment.

Huang SC, Ou AC, Park J, Yu F, Yu B, Lee A, Yang G, Zhou A, Benz EJ Jr. Huang SC, et al. Among authors: zhou a. Mol Cell Biol. 2012 Jan;32(2):513-26. doi: 10.1128/MCB.06423-11. Epub 2011 Nov 14. Mol Cell Biol. 2012. PMID: 22083953 Free PMC article.

3

Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection.

Zhou A, Ou AC, Cho A, Benz EJ Jr, Huang SC. Zhou A, et al. Mol Cell Biol. 2008 Oct;28(19):5924-36. doi: 10.1128/MCB.00560-08. Epub 2008 Jul 28. Mol Cell Biol. 2008. PMID: 18663000 Free PMC article.

4

Coupled transcription-splicing regulation of mutually exclusive splicing events at the 5' exons of protein 4.1R gene.

Huang SC, Cho A, Norton S, Liu ES, Park J, Zhou A, Munagala ID, Ou AC, Yang G, Wickrema A, Tang TK, Benz EJ Jr. Huang SC, et al. Among authors: zhou a. Blood. 2009 Nov 5;114(19):4233-42. doi: 10.1182/blood-2009-02-206219. Epub 2009 Sep 3. Blood. 2009. PMID: 19729518 Free PMC article.

5

Role of RBM25/LUC7L3 in abnormal cardiac sodium channel splicing regulation in human heart failure.

Gao G, Xie A, Huang SC, Zhou A, Zhang J, Herman AM, Ghassemzadeh S, Jeong EM, Kasturirangan S, Raicu M, Sobieski MA 2nd, Bhat G, Tatooles A, Benz EJ Jr, Kamp TJ, Dudley SC Jr. Gao G, et al. Among authors: zhou a. Circulation. 2011 Sep 6;124(10):1124-31. doi: 10.1161/CIRCULATIONAHA.111.044495. Epub 2011 Aug 22. Circulation. 2011. PMID: 21859973 Free PMC article.

6

Inhibition of PAX3 by TGF-beta modulates melanocyte viability.

Yang G, Li Y, Nishimura EK, Xin H, Zhou A, Guo Y, Dong L, Denning MF, Nickoloff BJ, Cui R. Yang G, et al. Among authors: zhou a. Mol Cell. 2008 Nov 21;32(4):554-63. doi: 10.1016/j.molcel.2008.11.002. Mol Cell. 2008. PMID: 19026785 Free article.

7

Case report: Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma.

Morecroft R, Phillipps J, Zhou A, Butt O, Khaddour K, Johanns T, Ansstas G. Morecroft R, et al. Among authors: zhou a. Front Oncol. 2024 May 8;14:1385094. doi: 10.3389/fonc.2024.1385094. eCollection 2024. Front Oncol. 2024. PMID: 38779101 Free PMC article.

8

Poly (ADP-Ribose) Polymerase inhibitors (PARPi) therapy response in an acral melanoma patient with EMSY gene amplification.

Nassief G, Butt OH, Zhou AY, Ansstas G. Nassief G, et al. Among authors: zhou ay. JAAD Case Rep. 2024 Apr 16;48:59-61. doi: 10.1016/j.jdcr.2024.04.005. eCollection 2024 Jun. JAAD Case Rep. 2024. PMID: 38778889 Free PMC article. No abstract available.

9

Ethics of Patients Losing Insurance Coverage Due to Hospital-Insurer Contract Disagreements.

Rao I, Zhou AE, Jain NP, Grant-Kels JM. Rao I, et al. Among authors: zhou ae. Clin Dermatol. 2024 May 20:S0738-081X(24)00081-6. doi: 10.1016/j.clindermatol.2024.05.007. Online ahead of print. Clin Dermatol. 2024. PMID: 38777205

10

A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma.

Qu W, Fu C, Han W, Luo H, Quan J, Chen L, Liao Y, Hu C, Hu H, Niu Y, Xu D, Chen M, Chen J, Liu Y, Chen G, Luo Z, Shi B, Sun Y, Zhou F, Zhou A. Qu W, et al. Among authors: zhou a. Eur J Cancer. 2024 May 10;205:114096. doi: 10.1016/j.ejca.2024.114096. Online ahead of print. Eur J Cancer. 2024. PMID: 38772302

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,231 results

Search Page